The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment
Open accessAbstract
Background: Long‐term treatment for atopic dermatitis (AD) using low dose, intermittent, topical anti‐inflammatory agents may control acute disease and prevent relapses. This 12‐month, European, multicentre, randomized study investigated whether the proactive use of 0.1% tacrolimus ointment applied twice weekly can keep AD in remission and reduce the incidence of disease exacerbations (DE). Methods: During the initial open‐label period, 257 adults with AD applied 0.1% tacrolimus ointment twice daily (b.i.d.) for up to 6 weeks to affected areas. When an Investigator Global Assessment (IGA) score of ≤2 was achieved, the patient entered the disease control period (DCP) and was randomized to either proactive tacrolimus (n = 116) or vehicle ointment (n = 108) twice weekly for 12 months. Exacerbations were treated with 0.1% tacrolimus ointment b.i.d. until an IGA ≤2 was regained, then randomized treatment was restarted. The primary endpoint was the number of DEs during the DCP that required a substantial therapeutic intervention. Results: Proactive tacrolimus 0.1% ointment application significantly reduced the number of DEs requiring substantial therapeutic intervention (median difference 2; P < 0.001; Wilcoxon rank sum test), the percentage of DE treatment days (median difference: 15.2%; P < 0.001; Wilcoxon rank sum test) and increased the time to first DE (median 142 vs 15 days; P < 0.001; stratified log‐rank test). The adverse event profile was similar for the two treatment approaches. Conclusion: A 12‐month, twice weekly proactive tacrolimus ointment application was an effective treatment in most study patients which prevented, delayed and reduced the occurrence of AD exacerbations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis
Hanifin, J. M., Thurston, M., Omoto, M., Cherill, R., Tofte, S. J., Graeber, M., & Evaluator Group, T. E. (2001) · Experimental Dermatology · doi:10.1034/j.1600-0625.2001.100102.x · Cited by 1,200
Grading of the severity of atopic dermatitis.
Rajka, G., & Langeland, T. (1989) · PubMed · doi:10.2340/000155551441314 · Cited by 412
The Structure Of Normal Skin And The Morphology Of Atopic Eczema
Mihm, M. C., Soter, N. A., Dvorak, H. F., & Austen, K. F. (1976) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12514346 · Cited by 382
Safety and Efficacy of 1 Year of Tacrolimus Ointment Monotherapy in Adults With Atopic Dermatitis
Reitamo, S. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.8.999 · Cited by 378
Self-citationSkin barrier function, epidermal proliferation and differentiation in eczema
Proksch, E., Fölster-Holst, R., & Jensen, J.-M. (2006) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2006.06.003 · Cited by 374
Eichenfield, L. F., Lucky, A. W., Boguniewiczc, M., Langley, R. G. B., Cherille, R., Marshalle, K., Bushe, C., & Graeber, M. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.122187 · Cited by 366
Kang, S., Lucky, A. W., Pariser, D., Lawrence, I., & Hanifin, J. M. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109812 · Cited by 331
Berth-Jones, J., Damstra, R. J., Golsch, S., Livden, J. K., Van Hooteghem, O., Allegra, F., & Parker, C. A. (2003) · BMJ · doi:10.1136/bmj.326.7403.1367 · Cited by 320
Cited by
Langan, S. M., Irvine, A. D., & Weidinger, S. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31286-1 · Cited by 1,852
Guidelines of care for the management of atopic dermatitis
Eichenfield, L. F., Tom, W. L., Chamlin, S. L., Feldman, S. R., Hanifin, J. M., Simpson, E. L., Berger, T. G., Bergman, J. N., Cohen, D. E., Cooper, K. D., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.10.010 · Cited by 1,277
Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14891 · Cited by 1,181
Self-citationGuidelines for treatment of atopic eczema (atopic dermatitis) Part I
Ring, J., Alomar, A., Bieber, T., Deleuran, M., Fink‐Wagner, A., Gelmetti, C., Gieler, U., Lipozencic, J., Luger, T., Oranje, A. P., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04635.x · Cited by 683
Self-citationBieber, T. (2010) · Annals of Dermatology · doi:10.5021/ad.2010.22.2.125 · Cited by 557
Self-citation
Metadata
- Authors
- Wollenberg, A., Reitamo, S., Atzori, F., Lahfa, M., Ruzicka, T., Healy, E., Giannetti, A., Bieber, T., Vyas, J., Deleuran, M., & for the European Tacrolimus Ointment Study Group
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2008-04-25
- Volume
- 63
- Issue
- 6
- Pages
- 742-750
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1889663809
- Cited by
- 266
- References
- 18
- FWCI
- 21.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. https://app.cochat.ai/papers/10.1111/j.1398-9995.2007.01406.x-i1
- The paper
- Wollenberg, A., Reitamo, S., Atzori, F., Lahfa, M., Ruzicka, T., Healy, E., Giannetti, A., Bieber, T., Vyas, J., Deleuran, M., & for the European Tacrolimus Ointment Study Group. (2008). Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy. https://doi.org/10.1111/j.1398-9995.2007.01406.x-i1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.